Skip to main content
Log in

Functional mobility recovery predicts readmission to the surgical intensive care unit

  • Letter
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Schaller SJ, Scheffenbichler FT, Bose S et al (2019) Influence of the initial level of consciousness on early, goal-directed mobilization: a post hoc analysis. Intensive Care Med 45:201–210. https://doi.org/10.1007/S00134-019-05528-x

    Article  Google Scholar 

  2. Tipping CJ, Harrold M, Holland A et al (2017) The effects of active mobilisation and rehabilitation in ICU on mortality and function: a systematic review. Intensive Care Med 43:171–183. https://doi.org/10.1007/s00134-016-4612-0

    Article  PubMed  Google Scholar 

  3. Latronico N, Herridge M, Hopkins RO et al (2017) The ICM research agenda on intensive care unit-acquired weakness. Intensive Care Med 43:1270–1281. https://doi.org/10.1007/s00134-017-4757-5

    Article  PubMed  Google Scholar 

  4. Van Aerde N, Meersseman P, Debaveye Y et al (2020) Five-year impact of ICU-acquired neuromuscular complications: a prospective, observational study. Intensive Care Med. https://doi.org/10.1007/s00134-020-05927-5

    Article  PubMed  PubMed Central  Google Scholar 

  5. WHO (2001) International classification of functioning, disability and health: ICF: Short version. WHO, Geneva

    Google Scholar 

Download references

Acknowledgements

Members of the SICU Optimal Mobilization Team (SOMT): Flora T. Scheffenbichler, M.D.; Shannon Stillwell, DPT; Karuna Wongtangman, M.D.; Karen Waak, DPT; Xinling Xu, PhD; Nicola Latronico, M.D.

Funding

This study was funded by an unrestricted grant from Jeff and Judy Buzen to Matthias Eikermann. The funders had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; and the decision to submit the manuscript for publication (Grant Number 222302).

Author information

Authors and Affiliations

Authors

Consortia

Contributions

MH, SG, BT, XX and ME were involved in study concept and design. All authors participated in acquisition, analysis or interpretation of data. MH, SG, BT and ME took part in drafting of the manuscript. All authors revised the manuscript critically for important intellectual content. MH, SG, XX and ME participated in statistical analyses. All authors took part in final approval of the version to be published. ME had full access to all the data in the study and is the guarantor for the integrity of the data and the accuracy of the data analysis.

Corresponding author

Correspondence to Matthias Eikermann.

Ethics declarations

Conflicts of interest

Maximilian Hammer reports no disclosures. Stephanie D. Grabitz reports no disclosures. Bijan Teja reports no disclosures. Flora T. Scheffenbichler reports no disclosures. Shannon Stillwell reports no disclosures. Marjorie Serrano reports no disclosures. Karuna Wongtangman reports no disclosures. Karen Waak reports no disclosures. Xinling Xu reports no disclosures. Nicola Latronico reports no disclosures. Matthias Eikermann received research support from Merck not related to this manuscript; he also received research support for this study from Jeff and Judy Buzen.

Consent to participate

The need for informed consent was waived by the Institutional Review Board at Beth Israel Deaconess Medical Center (#2019P000510, Committee on Clinical investigations, BIDMC, Boston, MA).

Consent for publication

Not applicable.

Availability of data and material

Questions about data are handled by the corresponding author.

Code availability

Questions about code availability are handled by the corresponding author.

Ethical approval

This study was approved by the Institutional Review Board at Beth Israel Deaconess Medical Center (#2019P000510, Committee on Clinical investigations, BIDMC, Boston, MA).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Members of the SICU Optimal Mobilization Team (SOMT) are listed in "Acknowledgements" section.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 361 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hammer, M., Grabitz, S.D., Teja, B. et al. Functional mobility recovery predicts readmission to the surgical intensive care unit. Intensive Care Med 46, 1054–1056 (2020). https://doi.org/10.1007/s00134-020-05972-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-020-05972-0

Navigation